Updates from NUAgo Therapeutics, including scientific presentations, publications, and company announcements.
For inquiries related to these updates, please contact us at contactNUAgo@NUAgotherapeutics.com.
NUAgo Therapeutics CEO and Co-Founder joins the Empowered Patient Podcast
NUAgo Therapeutics CEO and Co-Founder, Robert Schickel, Ph.D., joins the Empowered Patient Podcast and Karen Jagoda to discuss developing small RNA (sRNA) therapies that target
Read Article
NUAgo Therapeutics CEO and Co-Founder participates in the World Economic Forum 2026.
NUAgo Therapeutics CEO and Co-Founder Robert Schickel, Ph.D., participates in the Litestream Ventures Family Office & Venture Capital Forum in Davos during the World Economic Forum 2026
Read Article
BIO International
The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.
Read ArticleBioEquity Europe
For more than 20 years, BioEquity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today.
Read Article6mer seed toxicity in tumor suppressive miRNAs
Identifies the rules for the “kill code“ and the basis of NUAgo’s Class-1 technology through a screen of all possible combinations of 6mer seeds sequences
Read ArticleThe Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
Describes NUAgo’s underlying technology, toxic 6-mer sequences, are functionally active in ovarian cancer cells and patient samples treated with platinum (Pt)-base chemotherapy agents, first-line in
Read Article
Discovery of cancer ‘kill code’ could inspire new treatments
Scientists at Northwestern University have discovered a “kill code” in every cell of the body that’s triggered by chemotherapy and that causes cancerous cells to
Read Article
Cancer ‘Super Assassin’: Huntington’s Disease Molecule Can Target and Kill All Tumor Cells, Scientists Find
Scientists have destroyed numerous types of human cancer cells with a toxic molecule characteristic of fatal genetic illness Huntington’s disease. The researchers hailed the molecule—which
Read Article